Publications

2017 / 2016 / 2015 / 2014 / 2013 /

Scientific Reports Journal 2017

2017

Health state dependent multiphoton induced autofluorescence in human 3D in vitro lung cancer model

Kilin V, Mas C, Constant S, Wolf JP and Bonacina L
Scientific Reports in press

Toxicology Letters 2017

2017

Genetic engineering of a 3D in vitro human airway model sensitive to carcinogens

Benainous H, Huang S, Wiszniewski L, Constant S and Mas C
Toxicology Letters 280S (2017) S112–S113

World Congress on Alternatives 2017

2017

Genetic engineering of a 3D in vitro human lung cancer model

Constant S, Benainous H, Huang S, Wiszniewski L and Mas C
ALTEX Proceedings 6(1)p126, 2017, Seattle 2017

ATS 2017 Congress

2017

Oncogenic Transformation of a Functional 3D Human Airway Epithelium for In Vitro Lung Cancer Modelling

Mas C, Benainous H, Huang S, Wisniewski L and Constant S
Am J Respir Crit Care Med 2017;195:A2370

ATLA journal 2016

2016

Establishment of a tumour–stroma airway model (OncoCilAir) to accelerate the development of human therapies against lung cancer

Mas C, Boda B, CaulFuty M, Huang S, Wiszniewski L and Constant S
Altern Lab Anim 44:479-485 (2016)

EUSAAT 2016 Congress

2016

OncoCilAir™: organotypic human in vitro model for lung cancer research

Constant S, Mas C, Benainous H, Boda B, Caulfuty M and Wiszniewski L
ALTEX Proceedings 5(1)p55, 2016, LINZ 2016

INTECH Journal 2015

2015

Advanced Human In vitro Models for the Discovery and Development of Lung Cancer Therapies

Samuel Constant, Song Huang, Ludovic Wisniewski and Christophe Mas
In Drug Discovery and Development - From Molecules to Medicine, (Omboon Vallisuta Ed.), InTech, pp. 83-103. ISBN: 978-953-51-2128-2 (2015)

EUSAAT 2015 Congress

2015

Evaluation of selumetinib and trametinib MEK inhibitors antitumor efficacy in a preclinical in vitro human lung cancer model

Mas C and Constant S
ALTEX Proceedings 4(2)p48, 2015, Linz 2015

Hold your Breath

2015

Hold Your Breath

S Huang, L Wiszniewski, S Constant, C Mas European Biopharmaceutical Review - January 2015

Journal of Biotechnology 2015

2015

Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway-tumour-stroma lung cancer model

Mas C, Boda B, CaulFuty M, Huang S, Wiszniewski L and Constant S
J Biotechnol 205:111-9 (2015)